These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15687540)

  • 61. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
    Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
    Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Late restenosis following placement of a sirolimus eluting stent for in-stent restenosis.
    Ali OA; Lowe H; Kritharides L; Brieger D
    Heart Lung Circ; 2007 Feb; 16(1):50-1. PubMed ID: 17196881
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
    Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
    [TBL] [Abstract][Full Text] [Related]  

  • 64. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial.
    van Hout BA; Serruys PW; Lemos PA; van den Brand MJ; van Es GA; Lindeboom WK; Morice MC
    Heart; 2005 Apr; 91(4):507-12. PubMed ID: 15772214
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Consistent success with coated stents. Coronary arteries stay open longer].
    MMW Fortschr Med; 2002 May; 144(21):59. PubMed ID: 12134433
    [No Abstract]   [Full Text] [Related]  

  • 66. The role of BMS in the drug eluting stent era: is still there any place for them?
    Fineschi M; Gori T
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):456; author reply 457. PubMed ID: 16892446
    [No Abstract]   [Full Text] [Related]  

  • 67. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
    Tsuchiya Y; Lansky AJ; Costa RA; Mehran R; Pietras C; Shimada Y; Sonoda S; Cristea E; Negoita M; Dangas GD; Moses JW; Leon MB; Fitzgerald PJ; Müller R; Störger H; Hauptmann KE; Grube E
    Am J Cardiol; 2006 Aug; 98(4):464-9. PubMed ID: 16893698
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.
    Suttorp MJ; Laarman GJ; Rahel BM; Kelder JC; Bosschaert MA; Kiemeneij F; Ten Berg JM; Bal ET; Rensing BJ; Eefting FD; Mast EG
    Circulation; 2006 Aug; 114(9):921-8. PubMed ID: 16908768
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Can oral sirolimus therapy prevent in-stent restenosis?
    Schiele TM
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):76-7. PubMed ID: 16265374
    [No Abstract]   [Full Text] [Related]  

  • 71. Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry.
    Costa M; Angiolillo DJ; Teirstein P; Gilmore P; Leon M; Moses J; Yakubov S; Carter A; Fischell T; Zenni M; Bass T
    J Invasive Cardiol; 2005 Aug; 17(8):396-8. PubMed ID: 16079441
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
    Abizaid A; Lansky AJ; Fitzgerald PJ; Tanajura LF; Feres F; Staico R; Mattos L; Abizaid A; Chaves A; Centemero M; Sousa AG; Sousa JE; Zaugg MJ; Schwartz LB
    Am J Cardiol; 2007 May; 99(10):1403-8. PubMed ID: 17493469
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients.
    Kim MH; Hong SJ; Cha KS; Park HS; Chae SC; Hur SH; Gwon HC; Bae JH; Lim DS
    J Interv Cardiol; 2008 Jun; 21(3):225-31. PubMed ID: 18341520
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lessons from the E-SIRIUS trial.
    Schofer J
    Ital Heart J; 2004 Jan; 5(1):1-2. PubMed ID: 15080572
    [No Abstract]   [Full Text] [Related]  

  • 75. The influence of low (81 mg) versus high (325 mg) doses of ASA on the incidence of sirolimus-eluting stent thrombosis.
    Joyal D; Freihage JH; Cohoon K; Tempelhof M; Leya F; Dieter RS; Steen L; Lewis B; Arab D
    J Invasive Cardiol; 2007 Jul; 19(7):291-4. PubMed ID: 17620672
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.
    Grube E; Sonoda S; Ikeno F; Honda Y; Kar S; Chan C; Gerckens U; Lansky AJ; Fitzgerald PJ
    Circulation; 2004 May; 109(18):2168-71. PubMed ID: 15123533
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug coated stents for carotid intervention.
    Tepe G; Schmehl J; Claussen CD; Ernemann U; Pereira P; Duda SH
    J Cardiovasc Surg (Torino); 2005 Jun; 46(3):249-59. PubMed ID: 15956922
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute and intermediate-term procedural results using cypher stenting to treat multi-vessel coronary artery disease.
    Kornowski R; Vaknin-Assa H; Assali A; Fuchs S
    Int J Cardiovasc Intervent; 2005; 7(3):122-5. PubMed ID: 16243732
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Utility of three-dimensional reconstruction of coronary angiography to guide percutaneous coronary intervention.
    Gollapudi RR; Valencia R; Lee SS; Wong GB; Teirstein PS; Price MJ
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):479-82. PubMed ID: 17192961
    [TBL] [Abstract][Full Text] [Related]  

  • 80. One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registry.
    Sanmartin M; Baz JA; Lozano I; de la Torre JM; Hernandez JM; Bordes P; Mainar V; Mauri J; Iñiguez A
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):372-7. PubMed ID: 17195194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.